MongoDB, Inc. (NASDAQ: MDB) Stock Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
02/14/2024 | 14.56% | Keybanc | $500 → $543 | Maintains | Overweight |
01/26/2024 | -14.56% | DA Davidson | → $405 | Initiates Coverage On | → Neutral |
01/22/2024 | -7.17% | JMP Securities | → $440 | Reiterates | Market Outperform → Market Outperform |
01/17/2024 | 4.43% | Needham | → $495 | Reiterates | Buy → Buy |
01/04/2024 | -13.5% | UBS | $475 → $410 | Downgrades | Buy → Neutral |
12/06/2023 | -11.39% | Mizuho | $330 → $420 | Maintains | Neutral |
12/06/2023 | 0.21% | RBC Capital | $445 → $475 | Maintains | Outperform |
12/06/2023 | 0.85% | Barclays | $470 → $478 | Maintains | Overweight |
12/06/2023 | 4.43% | Needham | $445 → $495 | Maintains | Buy |
12/06/2023 | 5.49% | Piper Sandler | $425 → $500 | Maintains | Overweight |
12/04/2023 | -5.06% | Stifel | → $450 | Reiterates | Buy → Buy |
11/16/2023 | 5.49% | Wells Fargo | → $500 | Initiates Coverage On | → Overweight |
11/13/2023 | -9.28% | Truist Securities | → $430 | Reiterates | Buy → Buy |
11/08/2023 | -9.91% | Capital One | → $427 | Upgrades | Equal-Weight → Overweight |
10/23/2023 | -7.17% | Keybanc | $495 → $440 | Maintains | Overweight |
10/12/2023 | -5.06% | B of A Securities | → $450 | Initiates Coverage On | → Buy |
10/10/2023 | -29.32% | Scotiabank | → $335 | Initiates Coverage On | → Sector Perform |
10/06/2023 | 4.43% | Tigress Financial | $490 → $495 | Reiterates | Buy → Buy |
09/05/2023 | -5.06% | Canaccord Genuity | $410 → $450 | Maintains | Buy |
09/05/2023 | 2.11% | Argus Research | $435 → $484 | Maintains | Buy |
09/01/2023 | -1.9% | UBS | $425 → $465 | Maintains | Buy |
09/01/2023 | -9.28% | Truist Securities | $420 → $430 | Maintains | Buy |
09/01/2023 | 1.27% | Morgan Stanley | $440 → $480 | Maintains | Overweight |
09/01/2023 | -6.12% | RBC Capital | → $445 | Reiterates | Outperform → Outperform |
09/01/2023 | -5.06% | Barclays | $421 → $450 | Maintains | Overweight |
09/01/2023 | -47.26% | Guggenheim | $220 → $250 | Maintains | Sell |
09/01/2023 | -5.06% | Stifel | $420 → $450 | Maintains | Buy |
09/01/2023 | 1.27% | Oppenheimer | $430 → $480 | Maintains | Outperform |
09/01/2023 | -7.17% | JMP Securities | $425 → $440 | Maintains | Market Outperform |
09/01/2023 | -6.12% | Needham | $430 → $445 | Maintains | Buy |
09/01/2023 | -10.34% | Piper Sandler | $400 → $425 | Maintains | Overweight |
08/28/2023 | -4.01% | Citigroup | $430 → $455 | Maintains | Buy |
07/24/2023 | -10.34% | JMP Securities | $400 → $425 | Maintains | Outperform |
07/21/2023 | -2.53% | Keybanc | $372 → $462 | Maintains | Overweight |
06/28/2023 | 3.38% | Tigress Financial | $365 → $490 | Maintains | Buy |
06/26/2023 | -11.18% | Barclays | $374 → $421 | Maintains | Overweight |
06/26/2023 | -16.45% | Capital One | → $396 | Initiates Coverage On | → Equal-Weight |
06/23/2023 | -11.39% | Truist Securities | $365 → $420 | Maintains | Buy |
06/23/2023 | -7.17% | Morgan Stanley | $270 → $440 | Maintains | Overweight |
06/23/2023 | -6.12% | RBC Capital | $400 → $445 | Maintains | Outperform |
06/23/2023 | -13.5% | Wedbush | → $410 | Reiterates | Outperform → Outperform |
06/23/2023 | -9.28% | Needham | → $430 | Reiterates | Buy → Buy |
06/23/2023 | -15.61% | Piper Sandler | → $400 | Reiterates | Overweight → Overweight |
06/06/2023 | -13.5% | Canaccord Genuity | $250 → $410 | Maintains | Buy |
06/05/2023 | -11.39% | Goldman Sachs | $280 → $420 | Maintains | Buy |
06/05/2023 | -10.55% | Bernstein | $257 → $424 | Maintains | Outperform |
06/02/2023 | -15.61% | RBC Capital | $235 → $400 | Maintains | Outperform |
06/02/2023 | -20.88% | Stifel | $240 → $375 | Maintains | Buy |
06/02/2023 | -22.99% | Truist Securities | $235 → $365 | Maintains | Buy |
06/02/2023 | -53.59% | Mizuho | $180 → $220 | Maintains | Neutral |
06/02/2023 | -9.28% | Oppenheimer | $270 → $430 | Maintains | Outperform |
06/02/2023 | -9.28% | Needham | $250 → $430 | Maintains | Buy |
06/02/2023 | -17.72% | Baird | $290 → $390 | Maintains | Outperform |
06/02/2023 | -9.28% | Citigroup | $363 → $430 | Maintains | Buy |
06/02/2023 | -21.1% | Barclays | $280 → $374 | Maintains | Overweight |
06/02/2023 | -21.94% | JMP Securities | $245 → $370 | Maintains | Market Outperform |
06/02/2023 | -11.39% | Goldman Sachs | $280 → $420 | Maintains | Buy |
06/02/2023 | -15.61% | Piper Sandler | $270 → $400 | Maintains | Overweight |
05/31/2023 | -38.82% | Baird | $230 → $290 | Maintains | Outperform |
05/26/2023 | -55.7% | Guggenheim | $205 → $210 | Downgrades | Neutral → Sell |
05/19/2023 | -23.42% | Citigroup | $290 → $363 | Maintains | Buy |
05/15/2023 | -40.93% | Barclays | $257 → $280 | Maintains | Overweight |
04/20/2023 | -22.99% | Tigress Financial | → $365 | Reiterates | → Buy |
04/20/2023 | -44.3% | Keybanc | $229 → $264 | Maintains | Overweight |
04/12/2023 | -43.04% | Morgan Stanley | $230 → $270 | Upgrades | Equal-Weight → Overweight |
03/10/2023 | -47.26% | Credit Suisse | $305 → $250 | Maintains | Outperform |
03/09/2023 | -51.48% | Baird | → $230 | Maintains | Outperform |
03/09/2023 | -50.42% | RBC Capital | → $235 | Reiterates | → Outperform |
03/09/2023 | -40.93% | Goldman Sachs | $325 → $280 | Maintains | Buy |
03/09/2023 | -47.26% | Needham | $240 → $250 | Maintains | Buy |
03/09/2023 | -62.02% | Mizuho | $220 → $180 | Maintains | Neutral |
03/09/2023 | -38.82% | Citigroup | $295 → $290 | Maintains | Buy |
03/09/2023 | -43.04% | Oppenheimer | $320 → $270 | Maintains | Outperform |
03/09/2023 | -48.31% | JMP Securities | $215 → $245 | Maintains | Market Outperform |
03/09/2023 | -45.78% | Barclays | $264 → $257 | Maintains | Overweight |
03/09/2023 | -43.04% | Piper Sandler | → $270 | Reiterates | → Overweight |
03/07/2023 | -37.76% | Citigroup | $300 → $295 | Maintains | Buy |
02/22/2023 | -49.37% | Stifel | $256 → $240 | Maintains | Buy |
02/17/2023 | -40.51% | Bernstein | → $282 | Initiates Coverage On | → Outperform |
02/15/2023 | -44.3% | Barclays | $240 → $264 | Maintains | Overweight |
02/15/2023 | -53.59% | Mizuho | $170 → $220 | Maintains | Neutral |
02/06/2023 | -46.2% | Keybanc | $220 → $255 | Maintains | Overweight |
01/27/2023 | -56.75% | Guggenheim | → $205 | Initiates Coverage On | → Neutral |
01/08/2023 | -50.42% | Truist Securities | $300 → $235 | Maintains | Buy |
12/21/2022 | -49.37% | Needham | $225 → $240 | Maintains | Buy |
12/15/2022 | -22.99% | Tigress Financial | $575 → $365 | Maintains | Buy |
12/15/2022 | -49.37% | Wedbush | → $240 | Initiates Coverage On | → Outperform |
12/07/2022 | -45.99% | Stifel | $320 → $256 | Maintains | Buy |
12/07/2022 | -32.49% | Oppenheimer | $375 → $320 | Maintains | Outperform |
12/07/2022 | -51.48% | Morgan Stanley | $215 → $230 | Maintains | Equal-Weight |
12/07/2022 | -31.43% | Goldman Sachs | $380 → $325 | Maintains | Buy |
12/07/2022 | -49.37% | Barclays | $233 → $240 | Maintains | Overweight |
12/07/2022 | -35.65% | Credit Suisse | $400 → $305 | Maintains | Outperform |
12/07/2022 | -64.13% | Mizuho | $190 → $170 | Maintains | Neutral |
12/07/2022 | -54.64% | UBS | $200 → $215 | Maintains | Buy |
12/07/2022 | -54.64% | JMP Securities | → $215 | Upgrades | Market Perform → Market Outperform |
12/07/2022 | -52.53% | Needham | $330 → $225 | Maintains | Buy |
12/05/2022 | -56.75% | Baird | $330 → $205 | Maintains | Outperform |
11/29/2022 | -57.81% | UBS | $390 → $200 | Maintains | Buy |
11/28/2022 | -37.76% | Citigroup | $445 → $295 | Maintains | Buy |
11/21/2022 | -54.64% | Keybanc | → $215 | Initiates Coverage On | → Overweight |
11/21/2022 | -54.64% | Morgan Stanley | $368 → $215 | Downgrades | Overweight → Equal-Weight |
11/18/2022 | -50.84% | Barclays | $300 → $233 | Maintains | Overweight |
11/15/2022 | -59.91% | Mizuho | $300 → $190 | Maintains | Neutral |
10/20/2022 | -43.04% | Piper Sandler | $350 → $270 | Maintains | Overweight |
10/18/2022 | — | Redburn Partners | Upgrades | Sell → Neutral | |
10/18/2022 | -36.71% | Barclays | $360 → $300 | Maintains | Overweight |
09/30/2022 | -36.71% | Truist Securities | → $300 | Initiates Coverage On | → Buy |
09/01/2022 | -32.49% | Stifel | $340 → $320 | Maintains | Buy |
09/01/2022 | -24.05% | Canaccord Genuity | $300 → $360 | Maintains | Buy |
09/01/2022 | -30.38% | Baird | $360 → $330 | Maintains | Outperform |
09/01/2022 | -17.72% | UBS | $430 → $390 | Maintains | Buy |
09/01/2022 | -15.61% | Credit Suisse | $500 → $400 | Maintains | Outperform |
09/01/2022 | -30.38% | Needham | $350 → $330 | Maintains | Buy |
09/01/2022 | -26.16% | RBC Capital | $400 → $350 | Maintains | Outperform |
09/01/2022 | -6.12% | Citigroup | $450 → $445 | Maintains | Buy |
09/01/2022 | -24.05% | Barclays | $438 → $360 | Maintains | Overweight |
09/01/2022 | -26.16% | Piper Sandler | $375 → $350 | Maintains | Overweight |
08/22/2022 | -5.06% | Citigroup | $425 → $450 | Maintains | Buy |
08/17/2022 | -17.72% | Mizuho | $270 → $390 | Maintains | Buy |
08/16/2022 | -7.59% | Barclays | $338 → $438 | Maintains | Overweight |
07/18/2022 | -20.88% | Piper Sandler | $430 → $375 | Maintains | Overweight |
07/13/2022 | -24.05% | Baird | → $360 | Initiates Coverage On | → Outperform |
06/29/2022 | -59.91% | Redburn Partners | → $190 | Initiates Coverage On | → Sell |
06/10/2022 | -26.16% | Needham | $310 → $350 | Maintains | Buy |
06/09/2022 | -20.88% | RBC Capital | $325 → $375 | Maintains | Outperform |
06/08/2022 | -27.21% | UBS | $315 → $345 | Maintains | Buy |
06/02/2022 | -10.34% | Citigroup | $405 → $425 | Maintains | Buy |
06/02/2022 | -28.27% | Stifel | $425 → $340 | Maintains | Buy |
06/02/2022 | -36.71% | Canaccord Genuity | $400 → $300 | Maintains | Buy |
06/02/2022 | -22.36% | Morgan Stanley | $378 → $368 | Maintains | Overweight |
06/02/2022 | 5.49% | Credit Suisse | $650 → $500 | Maintains | Outperform |
06/02/2022 | -15.61% | Oppenheimer | $490 → $400 | Maintains | Outperform |
06/02/2022 | -28.69% | Barclays | $330 → $338 | Maintains | Overweight |
06/02/2022 | -34.6% | Needham | $362 → $310 | Maintains | Buy |
06/02/2022 | -9.28% | Piper Sandler | $585 → $430 | Maintains | Overweight |
06/01/2022 | -14.56% | Citigroup | $525 → $405 | Maintains | Buy |
05/20/2022 | -30.38% | Barclays | $410 → $330 | Maintains | Overweight |
05/19/2022 | -20.25% | Morgan Stanley | $475 → $378 | Maintains | Overweight |
05/18/2022 | -43.04% | Mizuho | $325 → $270 | Maintains | Neutral |
03/18/2022 | -5.06% | UBS | $345 → $450 | Upgrades | Neutral → Buy |
03/16/2022 | 0.21% | Morgan Stanley | $633 → $475 | Maintains | Overweight |
03/09/2022 | -10.34% | Stifel | $550 → $425 | Maintains | Buy |
03/09/2022 | -23.63% | Needham | $626 → $362 | Maintains | Buy |
03/09/2022 | -31.43% | Mizuho | $400 → $325 | Maintains | Neutral |
03/09/2022 | -13.5% | Barclays | $556 → $410 | Maintains | Overweight |
03/09/2022 | 37.13% | Credit Suisse | $700 → $650 | Maintains | Outperform |
03/01/2022 | 6.54% | RBC Capital | → $505 | Initiates Coverage On | → Outperform |
02/15/2022 | -15.61% | Mizuho | $490 → $400 | Maintains | Neutral |
02/11/2022 | 32.91% | Tigress Financial | → $630 | Initiates Coverage On | → Buy |
12/16/2021 | 33.55% | Morgan Stanley | $525 → $633 | Maintains | Overweight |
12/08/2021 | 14.98% | Goldman Sachs | $475 → $545 | Maintains | Buy |
12/07/2021 | 16.04% | Stifel | $495 → $550 | Maintains | Buy |
12/07/2021 | 18.15% | Canaccord Genuity | $475 → $560 | Maintains | Buy |
12/07/2021 | 10.76% | Morgan Stanley | $480 → $525 | Maintains | Overweight |
12/07/2021 | 39.24% | Citigroup | $526 → $660 | Maintains | Buy |
12/07/2021 | 3.38% | Mizuho | $475 → $490 | Maintains | Neutral |
12/07/2021 | 32.07% | Needham | $534 → $626 | Maintains | Buy |
12/07/2021 | 23.42% | Piper Sandler | $525 → $585 | Maintains | Overweight |
11/16/2021 | 47.68% | Credit Suisse | → $700 | Initiates Coverage On | → Outperform |
09/17/2021 | 24.48% | Barclays | $505 → $590 | Maintains | Overweight |
09/07/2021 | 16.04% | Argus Research | $406 → $550 | Maintains | Buy |
09/03/2021 | 4.43% | Stifel | $384 → $495 | Maintains | Buy |
09/03/2021 | -5.06% | UBS | $300 → $450 | Maintains | Neutral |
09/03/2021 | 1.27% | Morgan Stanley | $410 → $480 | Maintains | Overweight |
09/03/2021 | -0.84% | Oppenheimer | $400 → $470 | Maintains | Outperform |
09/03/2021 | 12.66% | Needham | $415 → $534 | Maintains | Buy |
09/03/2021 | -13.5% | Mizuho | $350 → $410 | Maintains | Neutral |
09/03/2021 | 6.54% | Barclays | $420 → $505 | Maintains | Overweight |
09/03/2021 | 10.76% | Piper Sandler | $425 → $525 | Maintains | Overweight |
08/24/2021 | -13.5% | Morgan Stanley | $377 → $410 | Maintains | Overweight |
08/23/2021 | -11.39% | Barclays | $390 → $420 | Maintains | Overweight |
07/14/2021 | -16.66% | Canaccord Genuity | $375 → $395 | Maintains | Buy |
07/14/2021 | -32.49% | Mizuho | $300 → $320 | Maintains | Neutral |
06/04/2021 | -5.06% | Citigroup | $445 → $450 | Maintains | Buy |
06/04/2021 | -36.71% | UBS | $325 → $300 | Maintains | Neutral |
06/04/2021 | -36.71% | Mizuho | $265 → $300 | Maintains | Neutral |
06/04/2021 | -12.45% | Needham | $409 → $415 | Maintains | Buy |
05/25/2021 | -20.46% | Morgan Stanley | $415 → $377 | Maintains | Overweight |
05/14/2021 | -34.6% | Goldman Sachs | → $310 | Initiates Coverage On | → Buy |
04/13/2021 | -32.49% | Mizuho | → $320 | Initiates Coverage On | → Neutral |
03/23/2021 | -31.43% | UBS | → $325 | Initiates Coverage On | → Neutral |
03/12/2021 | -14.34% | Argus Research | → $406 | Upgrades | Hold → Buy |
03/10/2021 | -36.71% | DA Davidson | $275 → $300 | Maintains | Neutral |
03/10/2021 | -12.45% | Morgan Stanley | $439 → $415 | Maintains | Overweight |
03/10/2021 | -20.88% | Canaccord Genuity | $430 → $375 | Maintains | Buy |
03/10/2021 | -13.71% | Needham | $394 → $409 | Maintains | Buy |
02/23/2021 | 5.49% | Citigroup | $465 → $500 | Maintains | Buy |
01/19/2021 | -16.88% | Needham | $341 → $394 | Maintains | Buy |
12/21/2020 | -18.99% | Stifel | $320 → $384 | Maintains | Buy |
12/17/2020 | -7.38% | Morgan Stanley | $295 → $439 | Upgrades | Equal-Weight → Overweight |
12/09/2020 | -33.54% | Canaccord Genuity | $290 → $315 | Maintains | Buy |
12/09/2020 | -28.06% | Needham | $290 → $341 | Maintains | Buy |
12/09/2020 | -30.8% | Piper Sandler | $310 → $328 | Maintains | Overweight |
12/07/2020 | -37.76% | Morgan Stanley | $270 → $295 | Maintains | Equal-Weight |
09/03/2020 | -39.45% | Barclays | $280 → $287 | Maintains | Overweight |
09/03/2020 | -32.49% | Stifel | $225 → $320 | Maintains | Buy |
09/03/2020 | -48.31% | Goldman Sachs | $215 → $245 | Maintains | Neutral |
09/03/2020 | -38.82% | Canaccord Genuity | $245 → $290 | Maintains | Buy |
09/03/2020 | -43.04% | Morgan Stanley | $205 → $270 | Maintains | Equal-Weight |
09/03/2020 | -41.98% | Oppenheimer | $240 → $275 | Maintains | Outperform |
09/03/2020 | -38.82% | Needham | $259 → $290 | Maintains | Buy |
09/03/2020 | -34.6% | Piper Sandler | $226 → $310 | Maintains | Overweight |
06/11/2020 | -56.75% | Morgan Stanley | $203 → $205 | Maintains | Equal-Weight |
06/05/2020 | -52.32% | Piper Sandler | $138 → $226 | Maintains | Overweight |
06/05/2020 | -45.36% | Needham | $253 → $259 | Maintains | Buy |
06/02/2020 | -46.62% | Needham | $170 → $253 | Maintains | Buy |
06/01/2020 | -57.17% | Morgan Stanley | $141 → $203 | Maintains | Equal-Weight |
05/28/2020 | -41.98% | Citigroup | $175 → $275 | Maintains | Buy |
05/22/2020 | -52.53% | Stifel | $160 → $225 | Maintains | Buy |
04/27/2020 | -64.13% | Needham | $172 → $170 | Maintains | Buy |
04/20/2020 | -66.24% | Stifel | $135 → $160 | Maintains | Buy |
03/18/2020 | -63.71% | Needham | $189 → $172 | Maintains | Buy |
03/18/2020 | -71.52% | Stifel | $185 → $135 | Maintains | Buy |
03/18/2020 | -63.08% | Citigroup | $200 → $175 | Maintains | Buy |
01/13/2020 | -63.92% | Morgan Stanley | $160 → $171 | Maintains | Equal-Weight |
01/06/2020 | — | Argus Research | Initiates Coverage On | → Hold | |
12/10/2019 | -65.19% | Canaccord Genuity | $185 → $165 | Maintains | Buy |
12/10/2019 | -66.24% | Morgan Stanley | $150 → $160 | Maintains | Equal-Weight |
12/10/2019 | -83.54% | Nomura | $76 → $78 | Maintains | Reduce |
10/29/2019 | -66.67% | Piper Sandler | → $158 | Initiates Coverage On | → Overweight |
10/16/2019 | -68.35% | Morgan Stanley | $160 → $150 | Maintains | Equal-Weight |
10/11/2019 | -67.3% | Oppenheimer | $180 → $155 | Maintains | Outperform |
09/05/2019 | -66.24% | Morgan Stanley | $156 → $160 | Maintains | Equal-Weight |
09/05/2019 | -60.97% | Stifel | $180 → $185 | Maintains | Buy |
09/05/2019 | -58.86% | Citigroup | $184 → $195 | Maintains | Buy |
09/05/2019 | -58.86% | Citigroup | $184 → $195 | Maintains | Buy |
09/05/2019 | -62.24% | Barclays | $178 → $179 | Maintains | Overweight |
08/27/2019 | -61.18% | Citigroup | $162 → $184 | Upgrades | Neutral → Buy |
08/13/2019 | -67.3% | Compass Point | → $155 | Initiates Coverage On | → Neutral |
06/19/2019 | -60.97% | Canaccord Genuity | $160 → $185 | Maintains | Buy |
06/19/2019 | -62.02% | Stifel | $155 → $180 | Maintains | Buy |
06/19/2019 | -60.34% | Keybanc | $165 → $188 | Maintains | Overweight |
06/06/2019 | -66.24% | Canaccord Genuity | $125 → $160 | Maintains | Buy |
06/06/2019 | -83.97% | Nomura | $70 → $76 | Maintains | Reduce |
06/06/2019 | -65.19% | Keybanc | $150 → $165 | Maintains | Overweight |
05/23/2019 | -67.72% | Morgan Stanley | $124 → $153 | Maintains | Equal-Weight |
05/15/2019 | -62.45% | Barclays | $143 → $178 | Maintains | Overweight |
03/14/2019 | -75.53% | Citigroup | $94 → $116 | Maintains | Neutral |
03/14/2019 | -73.63% | Canaccord Genuity | $95 → $125 | Maintains | Buy |
03/14/2019 | -68.35% | Keybanc | $100 → $150 | Maintains | Overweight |